Sánchez de Toledo Sancho J, Fàbrega Sabaté J, Marhuenda Irastorza C, Lucaya Layret X, Torán Fuentes N, Gros Subias L, Sábado Alvarez C
Servicio de Oncología Pediátrica, Hospital Vall d'Hebron, Barcelona, España.
An Pediatr (Barc). 2005 Jul;63(1):68-71. doi: 10.1157/13076770.
Castleman disease or angiofollicular hyperplasia is a rare disorder included in the group of lymphoproliferative disorders. This entity was originally described by Castleman in 1956. The etiology remains unknown but it is postulated to be a reactive lymphoid hyperplasia due to chronic antigenic stimulation caused by a viral infection. The disease presents in young adults and is more frequent in women; it is exceptionally rare in the pediatric age group. It is classified into two clinical groups (localized disease and disseminated disease) and there are two histologic variants (hyaline-vascular and plasma cell Castleman disease). Localized disease is usually asymptomatic, has a good prognosis, and is the most common presentation in pediatric patients, usually corresponding to highly vascularized mediastinal masses. Resection of the mass, which is curative, is associated with a high risk of blood loss. Recently, preoperative arteriography with embolization has been used satisfactorily in the preoperative management of these tumors. We present a case of localized Castleman disease in a 12-year-old girl satisfactorily treated with embolization before curative resection.
卡斯特leman病或血管滤泡性增生是一种罕见的疾病,属于淋巴增生性疾病。该疾病最初由卡斯特leman于1956年描述。病因尚不清楚,但据推测是由于病毒感染引起的慢性抗原刺激导致的反应性淋巴组织增生。该疾病多见于年轻人,女性更为常见;在儿童年龄组中极为罕见。它分为两个临床组(局限性疾病和播散性疾病),有两种组织学变体(透明血管型和浆细胞型卡斯特leman病)。局限性疾病通常无症状,预后良好,是儿科患者最常见的表现,通常对应于高度血管化的纵隔肿块。肿块切除可治愈,但与高失血风险相关。最近,术前动脉造影加栓塞术已成功用于这些肿瘤的术前管理。我们报告一例12岁女孩的局限性卡斯特leman病,在根治性切除术前通过栓塞术得到满意治疗。